Sectors
ORMP
Oramed Pharmaceuticals Inc.
5.02
2 x 3.60
2 x 6.32
bid
ask
-
0.01
0.20%
2 @ 07:33 PM
4.96 -0.06 (1.20%)
| Ytd | 76.14% | |
| 1y | 128.18% |
4.91
day range
5.06
2.09
52 week range
5.47
| Open | 5.03 | Prev Close | 5.03 | Low | 4.91 | High | 5.06 | Mkt Cap | 208.82M |
| Vol | 242.86K | Avg Vol | 303.11K | EPS | 4.12 | P/E | 1.22 | Forward P/E | -29.75 |
| Beta | 1.77 | Short Ratio | 2.60 | Inst. Own | 17.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 4.39 | 200-d Avg | 3.67 | 1yr Est | 3.25 |
| Income Statement | |||
| Operating Expenses | 2.77M | ||
| Selling, General and Administrative Expense | 2.77M | ||
| Operating Income | -2.77M | ||
| Interest Expense | -103.74M | ||
| Income Tax Expense | 23.43M | ||
| Net Income | 78.16M | ||
| Net Income Common Stock | 78.16M | ||
| Net Income Common Stock (USD) | 78.16M | ||
| Consolidated Income | 78.16M | ||
| Earnings per Basic Share | 1.90 | ||
| Earnings per Basic Share (USD) | 1.90 | ||
| Earnings per Diluted Share | 1.84 | ||
| Earning Before Interest & Taxes (EBIT) | -2.16M | ||
| Earning Before Interest & Taxes (USD) | -2.16M | ||
| Weighted Average Shares | 41.04M | ||
| Weighted Average Shares Diluted | 42.50M | ||
| Balance Sheet | |||
| Cash and Equivalents | 15.25M | ||
| Cash and Equivalents (USD) | 15.25M | ||
| Investments | 348.48M | ||
| Investments Current | 35.37M | ||
| Investments Non-Current | 313.12M | ||
| Trade and Non-Trade Receivables | 622.00K | ||
| Current Assets | 53.41M | ||
| Property, Plant & Equipment Net | 3.07M | ||
| Total Assets | 369.64M | ||
| Debt Current | 249.00K | ||
| Total Debt | 733.00K | ||
| Current Liabilities | 10.73M | ||
| Debt Non-Current | 484.00K | ||
| Total Liabilities | 52.17M | ||
| Accumulated Retained Earnings (Deficit) | -6.96M | ||
| Shareholders Equity | 317.47M | ||
| Shareholders Equity (USD) | 317.47M | ||
| Assets Non-Current | 316.24M | ||
| Total Debt (USD) | 733.00K | ||
| Deferred Revenue | 2.92M | ||
| Liabilities Non-Current | 41.44M | ||
| Trade and Non-Trade Payables | 8.51M | ||
| Tax Liabilities | 39.54M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 31.00K | ||
| Net Cash Flow from Financing | -1.95M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.04M | ||
| Capital Expenditure | -2.00K | ||
| Payment of Dividends & Other Cash Distributions | -78.00K | ||
| Net Cash Flow from Investing | 4.31M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.31M | ||
| Net Cash Flow from Operations | -200.00K | ||
| Effect of Exchange Rate Changes on Cash | -118.00K | ||
| Share Based Compensation | 1.39M | ||